Apparently, Humira was developed by Cambridge Antibody Technology in the United Kingdom (a collaboration of the government-funded Medical Research Council and three academics) and BASF Pharma/Knoll, which has roots in Germany. Abbot paid nearly 7 billion for rights and then made 100s billions on that drug and used those profits to acquire more drugs invented by others, that pretty much says it all about their business model.

Apparently, Humira was developed by Cambridge Antibody Technology in the United Kingdom (a collaboration of the government-funded Medical Research Council and three academics) and BASF Pharma/Knoll, which has roots in Germany. Abbot paid nearly 7 billion for rights and then made 100s billions on that drug and used those profits to acquire more drugs invented by others, that pretty much says it all about their business model.

user
yes
assistant